Showing results (181-190 of 309) with videos related to
Sort By:
Pageof 31
The American Journal of Medicine|April 29, 1998
Comparison of referring and tertiary cancer center physician's diagnoses in patients with leukemiaM DeLima, M Albitar, S O'Brien, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 1998
Humanized M195 monoclonal antibody conjugated to recombinant gelonin: an anti-CD33 immunotoxin with antileukemic activityL C Pagliaro, B Liu, R Munker, et al.Blood|February 15, 1992
Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA)E H Estey, R Kurzrock, H M Kantarjian, et al.Cytotherapy|June 4, 2002
High CD34 cell doses do not worsen regimen-related toxicity or early mortality after autologous blood stem cell transplantation for breast cancerI Braunschweig, N Q Mirza, G Rondon, et al.Cancer Research|April 1, 1994
Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alphaJ Drach, T McQueen, H Engel, et al.Leukemia|June 1, 1995
Fludarabine plus doxorubicin in previously treated chronic lymphocytic leukemiaL E Robertson, S O'Brien, H Kantarjian, et al.Blood|March 1, 1996
A pilot study of high-dose interleukin-3 treatment of relapsed follicular small cleaved-cell lymphoma: hematologic, immunologic, and clinical resultsA Younes, A Sarris, U Consoli, et al.Leukemia|December 1, 2009
Selective FLT3 inhibitor FI-700 neutralizes Mcl-1 and enhances p53-mediated apoptosis in AML cells with activating mutations of FLT3 through Mcl-1/Noxa axisK Kojima, M Konopleva, T Tsao, et al.Blood|April 21, 2001
Autocrine cell suicide in a Burkitt lymphoma cell line (Daudi) induced by interferon alpha: involvement of tumor necrosis factor as ligand for the CD95 receptorH Gisslinger, R Kurzrock, B Gisslinger, et al.Leukemia|December 19, 2012
HDAC inhibition by SNDX-275 (Entinostat) restores expression of silenced leukemia-associated transcription factors Nur77 and Nor1 and of key pro-apoptotic proteins in AMLL Zhou, V R Ruvolo, T McQueen, et al.Pageof 31